TiAB

About NTC

NTC is a private, R&D-focused Italian pharmaceutical company that has established itself as a leading European player in ophthalmic therapeutic solutions. Founded in 1990, the company has achieved significant growth, now distributing over 40 million units annually through a network of over 300 distributors in more than 100 countries. Its strategy is built on internal innovation, strategic acquisitions (like Pharmathen's ophthalmology business), and securing regulatory certifications (MDR for 20 devices) to strengthen its portfolio and market access.

Therapeutic Areas